IP Library Granted Patent US 10,485,604
Granted Patent B2
US 10,485,604 · App. 14/957,433 · Granted Nov 26, 2019

Vapor treatment of lung nodules and tumors

Inventors: Erik Henne (Seattle, WA); Robert Lawrence Barry (Kirkland, WA); Robert Alan Mest (Long Beach, CA)
Assignee: Uptake Medical Technology Inc.
A61B18/04A61B2018/00541A61B2018/00577A61B2018/048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,485,604
App. No.
14/957,433
Granted
Nov 26, 2019
Kind
B2
Abstract

Systems and methods for treating a lesion in a lung of a patient are described. Embodiments can include navigating a vapor exit port of a vapor delivery catheter to an airway point near a lung region in which the lesion resides, delivering condensable vapor from the vapor delivery catheter along anatomic boundaries of the lung region, and creating a uniform field of necrosis in tissue around the lesion by allowing the condensable vapor to condense.

Claims (17)

1. A method of treating a lesion in a lung of a patient, the method comprising: navigating a vapor exit port of a vapor delivery catheter along an airway and to a point near a lung region in which the lesion resides, and in which the lung region can be isolated from a portion of the airway, wherein the lung region comprises a lung segment, subsegment or sub-subsegment having segmental boundaries encompassing both the lesion and healthy tissue surrounding the lesion and extending to the segmental boundaries; delivering condensable vapor from the exit port of the vapor delivery catheter for a first treatment time into said lung region sufficient to create a uniform field of necrosis in the lesion, the healthy tissue around the lesion and along said segmental boundaries by allowing the condensable vapor to condense; and determining, prior to the step of delivering, a first amount of energy to cause said uniform field of necrosis in the healthy tissue around the lesion, and to cause a well-defined ablation boundary between the uniform field of necrosis in the healthy tissue around the lesion and healthy non-targeted tissue along the segmental boundaries; and wherein the determining step is based on an airway diameter at said point.

2. The method of claim 1 wherein the lung region is a subsegment of the lung.

3. The method of claim 1 wherein the lung region is a sub-subsegment of the lung.

4. The method of claim 1 wherein the delivering step comprises creating the uniform field of necrosis in healthy tissue around the lesion without charring this healthy tissue.

5. The method of claim 1 wherein the delivering step comprises creating the uniform field of necrosis in healthy tissue around the lesion without thermally fixing this healthy tissue.

6. The method of claim 1 wherein the delivering step comprises transferring 270-450 calories of energy from the condensable vapor to the lesion and healthy tissue around the lesion.

7. The method of claim 6 wherein the first treatment time is 8 seconds.

8. The method of claim 1 further comprising isolating the lung region from the portion of the airway at said point by expanding a balloon in the airway at said point.

9. The method of claim 1 wherein the first amount of energy is further correlated with bronchus generation.

10. The method of claim 1 wherein the first amount of energy ranges from 125 to 330 calories.

11. The method of claim 1 wherein the step of delivering limits a depth of ablation of neighboring healthy non-targeted tissue to approximately 1 mm from the well-defined ablation boundary.

12. A method of treating a lesion in a lung of a patient, the method comprising: navigating a vapor exit port of a vapor delivery catheter along an airway and to an isolation point near a lung sub-segment in which the lesion resides, and in which the lung sub-segment can be isolated from a portion of the airway, the lung sub-segment having segmental divisions encompassing both the lesion and tissue surrounding the lesion; delivering condensable vapor from the exit port of the vapor delivery catheter into said lung sub-segment sufficient to create a uniform ablation in tissue around the lesion and along said segmental divisions; determining, prior to the step of delivering, a correlated first amount of energy sufficient to cause (a) said uniform ablation in tissue around the lesion and along said segmental divisions and (b) a distinct collagen denaturation boundary that follows the segmental divisions; and wherein the first amount of energy is based on diameter of the airway at the point of isolation of the lung subsegment.

13. The method of claim 12 , wherein the first amount of energy is further correlated with bronchus generation.

14. The method of claim 12 , wherein the boundary includes pleural surfaces.

15. The method of claim 12 , wherein the step of delivering limits a depth of ablation of healthy non-targeted tissue to approximately 1 mm from the distinct collagen denaturation boundary.

16. The method of claim 12 , wherein the first amount of energy ranges from 270 to 450 calories.

17. The method of claim 16 , wherein the step of delivering has a duration of 8 seconds.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2016
From: UPTAKE MEDICAL CORP.
To: UPTAKE MEDICAL TECHNOLOGY INC.
Reel/Frame 039388/0053 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2016
From: HENNE, ERIK; BARRY, ROBERT LAWRENCE; MEST, ROBERT ALAN
To: UPTAKE MEDICAL CORP.
Reel/Frame 038976/0460 →
Continuity (2)
Provisional Application 62086606 · Dec 2, 2014
Related Publication 20160151103A1 · Jun 2, 2016